Lifecare: A step forward under the product development agreement with Sanofi - Redeye

Redeye comments on Lifecare following today’s news that the company has completed a key development phase and submitted a phase-end report to Sanofi, which holds a right of first refusal for Sencell in human use.

Länk till analysen i sin helhet: https://www.redeye.se/research/1049262/lifecare-a-step-forward-under-the-product-development-agreement-with-sanofi?utm_source=finwire&utm_medium=RSS